All Posts By

Smartkarma Daily Briefs

Daily Brief Macro: The Most Important Question For Equity Investors: What to Expect in Global Fixed Income in 2023? and more

By | Daily Briefs, Macro

In today’s briefing:

  • The Most Important Question For Equity Investors: What to Expect in Global Fixed Income in 2023?
  • Active China Funds:  Top-Down Positioning Update, 2023
  • Going for Gold
  • The Commodity Report #88
  • The Week That Was in ASEAN@Smartkarma -Bank Central Asia, Bank Negara Indonesia, and Central Retail.

The Most Important Question For Equity Investors: What to Expect in Global Fixed Income in 2023?

By Michael J. Howell

  • 2023 will prove far better for most investors. Although the major World stock and bond indexes will range sideways, several national markets and sectors will perform strongly
  • Behind our optimism is an expansion the all-important Global Liquidity cycle from last October. This is driven by the People’s Bank of China and paced by the US Federal Reserve
  • World fixed income markets are exhibiting a ‘normal’, not the distorted cycle many claim. Coming months should see skidding bond market volatility and the beginning of yield curve steepening

Active China Funds:  Top-Down Positioning Update, 2023

By Steven Holden

  • Active funds head in to 2023 overweight Industrials and Staples versus underweight Financials and Communication Services
  • Energy stocks are still only owned by 51% of funds yet captured the largest increase in ownership through 2022.  
  • China Banks are a key underweight.  Only 11% of funds are positioned ahead of the iShares MSCI China ETF benchmark.  Airlines, Casinos/Gaming and Airfreight/Couriers were the winners in 2022.

Going for Gold

By ByteTree Asset Management

  • With stocks up while the dollar is down, 2023 continues to surprise.
  • It was supposed to be the great recession, but the market says otherwise.
  • That is one of the confusions around gold. In this week’s Atlas Pulse, I compared the bull vs bear arguments. 

The Commodity Report #88

By The Commodity Report

  • The general market consensus going into the new year was that commodity prices would continue to correct.
  • We also positioned ourselves in this camp, as we predicted the turnaround story a few months later.
  • While some commodities such as wheat or natural gas (both commodities that had been priced in a risk bonus for a long time due to the Ukraine war) fell sharply, other commodities such as corn, soybeans, orange juice, or soybean meal remain not far from their highs.

The Week That Was in ASEAN@Smartkarma -Bank Central Asia, Bank Negara Indonesia, and Central Retail.

By Angus Mackintosh


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Most Read: SenseTime Group, PolyNovo Ltd, Adani Enterprises, Biocon Ltd, Nissan Motor, Tencent Music Entertainment Group, Jardine Matheson Holdings, Qingdao Haier Biomedical and more

By | Daily Briefs, Most Read

In today’s briefing:

  • MSCI Wants a Consult on Adani Group – I’m Not Sure What They Can Do
  • Index Rebalance & ETF Flow Recap: NKY, LQ45, New Deal, URA, NIFTY, Stock Connect, SenseTime, Adani
  • S&P/​​​​​​ASX Index Rebalance Preview: High Impact Changes in March
  • Adani Ent FPO – Early Demand Muted, Adani & Hindenburg Trade Barbs Again, But Not a Good Look
  • Smartkarma Webinar | This Is Not A Webinar On Adani
  • NIFTY100 Index Rebalance Preview: Big Impact & Could Increase Due to Capping
  • Renault & Nissan “Agree” On New Terms – A Diet Nothing🍔, Exchangeable into Shaq Fingerguns
  • Quiddity Flow Expectations HSTECH Mar 23: Two Index Changes Possible
  • Matheson To Exit Greatview Aseptic
  • STAR50 Index Rebalance Preview: 5 Changes Forecast as Review Period Ends

MSCI Wants a Consult on Adani Group – I’m Not Sure What They Can Do

By Travis Lundy

  • The Adani Group listcos have been on a wild ride for the last few years, rising from 10x TTM EV/EBITDA in March 2020 to 60x at end-September 2022. 
  • Adani Group “business incubator’ Adani Enterprises (ADE IN) last fall indicated it might raise $2.4bn of equity and combined 6 co market cap is down $135bn since.
  • A short seller report last week put the cat amongst the pigeons. Now MSCI is consulting investors about what it might do regarding Things.

Index Rebalance & ETF Flow Recap: NKY, LQ45, New Deal, URA, NIFTY, Stock Connect, SenseTime, Adani

By Brian Freitas


S&P/​​​​​​ASX Index Rebalance Preview: High Impact Changes in March

By Brian Freitas

  • We currently see 1 change for the ASX20, 2 for the ASX100, 4 changes for the ASX 200 and 9 adds/ 6 deletes for the ASX300 Index in March.
  • Passive trackers will need to trade over 3 days of ADV on 13 stocks, over 5 days of ADV on 9 stocks and over 10x ADV on 4 stocks. 
  • Shorts have been covering positions on stocks where there are expected to be passive inflows and increasing positions on stocks that are expected to have passive outflows.

Adani Ent FPO – Early Demand Muted, Adani & Hindenburg Trade Barbs Again, But Not a Good Look

By Travis Lundy

  • The Adani Enterprises (ADE IN) FPO saw VERY muted demand (realtime available on NSE+BSE websites) on Day 1 Friday as the share price plummeted through the bottom of the range.
  • The Adani Group responded to Hindenburg late Sunday with a 400-page rebuttal, cloaked in nationalistic terms. Hindenburg responded saying the company failed to answer 62 of 88 questions.
  • This is not going away. They could lower the FPO price, or just pull the FPO. That won’t materially change the significant over-valuation of many Adani Group listco share prices.

Smartkarma Webinar | This Is Not A Webinar On Adani

By Smartkarma Research

In the next installment of our Webinar Wednesdays, we go live with Smartkarma Insight Provider, Travis Lundy as he gives us a quick rundown about what is the current situation that is happening with Adani Enterprises and where they are headed from this point on.

The webinar will be hosted on Wednesday, 1 February 2023, 17:00 SGT/HKT.

Travis Lundy has 20+ years of experience in Asia doing alternative strategies (i.e. non-delta1 non long-only) in fixed income, equity derivatives, and activist/catalyst/event-driven and long-short equity strategies, with most of that time spent managing money.


NIFTY100 Index Rebalance Preview: Big Impact & Could Increase Due to Capping

By Brian Freitas

  • There are 2 trading days left in the review period. We expect 5 changes at the rebalance that will be announced end-February and implemented at the close on 30 March.
  • A lot of the stocks were AMFI migrations and Biocon Ltd (BIOS IN) is a potential deletion from the MSCI India Index at the February QCIR.
  • The drop in the Adani Group stocks that are part of the index will result in passive inflows on the non-F&O constituents due to capping at 15% of index weight.

Renault & Nissan “Agree” On New Terms – A Diet Nothing🍔, Exchangeable into Shaq Fingerguns

By Travis Lundy

  • Today, a Nikkei article suggested (after other media suggested last week) that Renault SA (RNO FP) and Nissan Motor (7201 JP) have come to agreement about their new deal.
  • Post-Close, an announcement. Two striking things about this “agreement” a) it comes many months after they started negotiating, and b) we have few details, and c) we’re missing a bit.
  • Renault agrees to cap voting rights in Nissan. Nissan agrees to invest in RNO’s EV spinoff, and so far, they agree to strengthen the Alliance. What’s missing is interesting/key.

Quiddity Flow Expectations HSTECH Mar 23: Two Index Changes Possible

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the potential index changes and the resultant capping flows for the Hang Seng Tech Index (HSTECH INDEX) in March 2023.
  • According to our estimation, there could be two changes for the HSTECH in March 2023 and there could be one-way index flows of US$365mn.
  • The final index changes along with indicative capping and index weights could be published in Mid/Late-February 2023 and implemented in early-March 2023.

Matheson To Exit Greatview Aseptic

By David Blennerhassett


STAR50 Index Rebalance Preview: 5 Changes Forecast as Review Period Ends

By Brian Freitas

  • The review period for the March rebalance ends today. We forecast 2 changes using a 12-month minimum listing history, and 5 changes using a 6-month minimum listing history.
  • We expect the index committee to continue using a 6-month minimum listing history. The impact on the potential deletes is a lot higher than the impact on the potential adds.
  • With 5 changes to the index, estimated one-way turnover is 5.1% resulting in a one-way trade of CNY 4,549m. There is a reasonably large reverse funding trade.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Australia: Pureprofile Ltd, SenSen Networks, X2M Connect ltd and more

By | Australia, Daily Briefs

In today’s briefing:

  • Pureprofile Ltd – Q2 Revenue Momentum Builds, Company Affirms Guidance
  • SenSen Networks – Record receipts and restructuring
  • X2M Connect Limited – Tracking In-Line Across Key Variables

Pureprofile Ltd – Q2 Revenue Momentum Builds, Company Affirms Guidance

By Research as a Service (RaaS)

  • Pureprofile Ltd (ASX:PPL) is a data analytics, consumer insights and media company underpinned by proprietary technology, servicing business decision makers in brands and media companies as well as market researchers.
  • The company has an established position delivering insights to clients across 89 countries and has captured through its panel fully declared, deep consumer profiles, first-party data and insights.
  • Pureprofile has reported a 21% increase in Q2 FY23 sales revenue to $12.8m and Q2 EBITDA of $1.2m, down 12%, or $0.2m, on the previous corresponding period due to the loss of income from the UK premises, new premises in India, forex losses and a bad debt provision. 

SenSen Networks – Record receipts and restructuring

By Edison Investment Research

SenSen Networks (SNS) maintained its streak of record year-on-year cash receipts in Q223, with customer receipts up 70% against Q222 to A$2.6m. SNS continues to see growth across its key verticals of smart cities, gaming, retail and surveillance, boosting annual recurring revenues (ARR) to c A$8m, and leaving the company well on track to meet management’s expected ARR of A$10m by the end of FY23. SNS’s operational restructuring and previously announced A$2.5m in cost saving efforts should support management’s goal of cash flow neutrality by the end of the fiscal year. These results lead us to maintain our forecasts and if SenSen can continue to grow ARR, then the valuation gap between peers can potentially close.


X2M Connect Limited – Tracking In-Line Across Key Variables

By Research as a Service (RaaS)

  • X2M Connect Limited (ASX:X2M) has updated several key variables in conjunction with its December quarter 4C release.
  • Most key variables were in-line or ahead of RaaS expectations including a cash-flow positive Q2, device growth of 23% on September 2022 to 361k (RaaS 345k), H1 FY23 revenue +96% to $9.0m (RaaS $9.2m), cash costs of ~$4.3m (RaaS $4.6m) and a cash balance of $3.05m.
  • Post-month end we estimate a cash balance closer to $3.5m on receipt of a $1.3m R&D credit offset by the repayment of a related R&D loan. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Singapore: Jardine Matheson Holdings and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Matheson To Exit Greatview Aseptic

Matheson To Exit Greatview Aseptic

By David Blennerhassett


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Thailand: Kasikornbank PCL and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Kasikornbank PCL (KBANK TB) – Replanting the Seeds of Growth

Kasikornbank PCL (KBANK TB) – Replanting the Seeds of Growth

By Angus Mackintosh

  • Kasikornbank PCL (KBANK TB) remains one of Thailand’s top-tier banks with particular strength in SME lending and consumer lending making it a beneficiary of both consumption and tourism recovery. 
  • The bank continues to grow its digital banking and business through its K PLUS app which now has more than 21m users, with multiple use cases and self-apply loan applications. 
  • Kasikornbank remains a core holding for exposure to Thailand’s tourism-driven recovery through its SME exposure. Valuations are attractive with the bank trading at 0.7x FY2023 PBV and 8.3% FY2023E ROE. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief South Korea: HMM Co., Ltd., Osstem Implant, Samsung C&T and more

By | Daily Briefs, South Korea

In today’s briefing:

  • HMM Is Likely the First to Be Subject to the Mandatory Offer that Comes into Force
  • Osstem Implant: Details of Tender Offer & Chairman Choi’s Children Exchange CB Call Options for BWs
  • Using Smartkarma/OWL ESG Analytics to Narrow Down List of Corporate Activism Targets in Korea

HMM Is Likely the First to Be Subject to the Mandatory Offer that Comes into Force

By Sanghyun Park

  • KDB recently initiated the process of selecting an advisory firm to sell its stake in HMM, which will likely be the first to implement the mandatory offer rule.
  • Potential bidders include Hyundai Glovis, LX Holdings, and Samsung SDS. As for POSCO Holdings, it recently said that it is not considering acquiring HMM.
  • Given that HMM is the only national shipping company, there is a good chance that multiple bidders will appear, which will lead to a premium to the market price.

Osstem Implant: Details of Tender Offer & Chairman Choi’s Children Exchange CB Call Options for BWs

By Douglas Kim

  • We provide details of the Osstem Implant tender offer as well as Chairman Choi’s children exchange of CB call options for BWs. 
  • We believe that the majority of the minority shareholders in Osstem Implant are not likely to sell their shares at 190,000 won per share but hold on to it. 
  • Over a longer time frame, Osstem’s share price could reach higher levels driven by its improving sales and profit growth, deep valuation discount to global peers, and further M&A fight. 

Using Smartkarma/OWL ESG Analytics to Narrow Down List of Corporate Activism Targets in Korea

By Douglas Kim

  • We discuss how to use the OWL ESG Analytics (available on Smartkarma) to narrow down the list of companies that could be the next targets of corporate activism in Korea. 
  • We go through in detail, step-by-step process of how to narrow down the list of companies, using the OWL ESG Analytics. 
  • Corporate activism has been one of the most important, market moving factors moving the Korean stock market this year.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Indonesia: Bukalapak and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • Bukalapak (BUKA IJ) – Thriving Within a Virtuous Circle

Bukalapak (BUKA IJ) – Thriving Within a Virtuous Circle

By Angus Mackintosh

  • Bukalapak (BUKA IJ)  is one of Indonesia’s most differentiated digital economy players plus it is unusual in that it has one of the longest runways amongst peers at 15 years. 
  • Despite operating a marketplace model, the platform uses this to generate traffic for its other businesses including its O2O Mitra Bukalapak business and its growing online speciality store business. 
  • Bukalapak (BUKA IJ) also has strong ESG credentials, the most obvious of which is in the empowerment of MSMEs through its Mitra business. It is also making headway toward profitability.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief India: Adani Enterprises, Concord Biotech Ltd, Gujarat Ambuja Exports, Vedanta Resources and more

By | Daily Briefs, India

In today’s briefing:

  • Adani Ent FPO – Early Demand Muted, Adani & Hindenburg Trade Barbs Again, But Not a Good Look
  • Smartkarma Webinar | This Is Not A Webinar On Adani
  • Concord Biotech Pre-IPO – Sales Have Been Growing but Watch Out for Its High Concentration Risk
  • Gujarat Ambuja Exports Ltd (GAEL): Forensic Analysis
  • Vedanta Resources – Earnings Flash – Q3 FY 2022-23 Results (Vedanta Ltd) – Lucror Analytics

Adani Ent FPO – Early Demand Muted, Adani & Hindenburg Trade Barbs Again, But Not a Good Look

By Travis Lundy

  • The Adani Enterprises (ADE IN) FPO saw VERY muted demand (realtime available on NSE+BSE websites) on Day 1 Friday as the share price plummeted through the bottom of the range.
  • The Adani Group responded to Hindenburg late Sunday with a 400-page rebuttal, cloaked in nationalistic terms. Hindenburg responded saying the company failed to answer 62 of 88 questions.
  • This is not going away. They could lower the FPO price, or just pull the FPO. That won’t materially change the significant over-valuation of many Adani Group listco share prices.

Smartkarma Webinar | This Is Not A Webinar On Adani

By Smartkarma Research

In the next installment of our Webinar Wednesdays, we go live with Smartkarma Insight Provider, Travis Lundy as he gives us a quick rundown about what is the current situation that is happening with Adani Enterprises and where they are headed from this point on.

The webinar will be hosted on Wednesday, 1 February 2023, 17:00 SGT/HKT.

Travis Lundy has 20+ years of experience in Asia doing alternative strategies (i.e. non-delta1 non long-only) in fixed income, equity derivatives, and activist/catalyst/event-driven and long-short equity strategies, with most of that time spent managing money.


Concord Biotech Pre-IPO – Sales Have Been Growing but Watch Out for Its High Concentration Risk

By Clarence Chu

  • Concord Biotech Ltd (658823Z IN) is looking to raise around US$250m in its upcoming India IPO.
  • Concord Biotech (Concord) is an India-based biopharma firm, which develops and manufactures fermentation-based active pharmaceutical ingredients (APIs).
  • As per F&S, it was one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on FY21 volume.

Gujarat Ambuja Exports Ltd (GAEL): Forensic Analysis

By Nitin Mangal

  • Gujarat Ambuja Exports (GAEX IN) is an Agro Processing conglomerate having a diverse product profile across oil seeds, edible oil refining, maize and starch, cotton yarn, wheat processing, etc. 
  • Our forensics primarily include the takeaways on MACPPL acquisition, its true rationale, accounting impact on the balance sheet and few disclosure errs.
  • Other major takeaway relates to capex story and grey areas relating to the capacity size and timely completion, especially for its marquee plant in Malda.

Vedanta Resources – Earnings Flash – Q3 FY 2022-23 Results (Vedanta Ltd) – Lucror Analytics

By Trung Nguyen

Vedanta Ltd’s (VEDL) Q3/22-23 results were weaker than expected, with thin profitability at the aluminium segment due to higher energy and commodity costs. However, we note positively the sale of Zinc International to Hindustan Zinc​ (HZL) and the fourth interim dividend (USD 570 mn). The financial risk metrics remain modest. The key risk remains the weak debt maturity profile, with large maturities in FY 2023-24.

Vedanta as a group has demonstrated a strong willingness to repay debt, and the capacity to do so by upstreaming cash as quickly as possible. In addition, we note the group’s creative methods to upstream cash efficiently, such as: [1] the sale of Zinc International to HZL; and [2] the merger between Cairn India and VEDL in 2017, when oil prices were low, with the deal partly funded by preference shares to Cairn India’s minority shareholders. We believe that the huge dividends by VEDL in FY 2022-23 (USD 3.7 bn) are the highest possible and will likely decline subsequently, given the correction in commodity prices. Still, this could offer comfort to lenders as it would support VRL’s refinancing needs (i.e. gap between the maturing debt and cash inflows).


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief China: Tencent Music Entertainment Group, Qingdao Haier Biomedical, Tencent, Greatview Aseptic Packaging, Evergrande, XPeng, Shanghai MicroPort MedBot Group, Alibaba Group, Seazen (Formerly Future Land), Hong Kong Hang Seng Index and more

By | China, Daily Briefs

In today’s briefing:

  • Quiddity Flow Expectations HSTECH Mar 23: Two Index Changes Possible
  • STAR50 Index Rebalance Preview: 5 Changes Forecast as Review Period Ends
  • Tencent (700 HK): Risen 100% in Three Months, But Still 21%~44% Upside
  • Greatview Aseptic (468 HK): Xinjufeng Technology Acquires Jardine Matheson’s Stake
  • Evergrande : Not Legit
  • Xpeng: Accelerated Model Launch Campaign May Surprise
  • Shanghai MicroPort MedBot Group (2252.HK) – Recognize the Reality but Don’t Give up Hope
  • Aequitas ASEAN Placements Bookrunner Performance (2019-2022)
  • Morning Views Asia:
  • China’s Green Loan Market: Fifty Shades of Green

Quiddity Flow Expectations HSTECH Mar 23: Two Index Changes Possible

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the potential index changes and the resultant capping flows for the Hang Seng Tech Index (HSTECH INDEX) in March 2023.
  • According to our estimation, there could be two changes for the HSTECH in March 2023 and there could be one-way index flows of US$365mn.
  • The final index changes along with indicative capping and index weights could be published in Mid/Late-February 2023 and implemented in early-March 2023.

STAR50 Index Rebalance Preview: 5 Changes Forecast as Review Period Ends

By Brian Freitas

  • The review period for the March rebalance ends today. We forecast 2 changes using a 12-month minimum listing history, and 5 changes using a 6-month minimum listing history.
  • We expect the index committee to continue using a 6-month minimum listing history. The impact on the potential deletes is a lot higher than the impact on the potential adds.
  • With 5 changes to the index, estimated one-way turnover is 5.1% resulting in a one-way trade of CNY 4,549m. There is a reasonably large reverse funding trade.

Tencent (700 HK): Risen 100% in Three Months, But Still 21%~44% Upside

By Ming Lu

  • We believe total revenue growth rate will accelerate from 4Q22 and grow by 9% in 2023.
  • We believe the operating margin will be stable from 4Q22 to 2Q23, but the margin will climb up from 3Q23.
  • We believe that EPS will increase by 16% and the stock will have an upside of 21%~44%.

Greatview Aseptic (468 HK): Xinjufeng Technology Acquires Jardine Matheson’s Stake

By Arun George


Evergrande : Not Legit

By Warut Promboon

  • The company has defaulted since 2021 and has already missed a few payments as well as the deadline to deliver a restructuring blueprint at the end of 2022.
  • We believe the Chinese government is looking now to rescue developers (such as Country Garden) which are seen as systemically important.  
  • We are of the opinion that the sector is not investable for the general public  in 2023 and only the Distressed specialists should endeavor investing in Chinese high-yield property developers.

Xpeng: Accelerated Model Launch Campaign May Surprise

By Victoria Li

  • Xpeng has announced it is speeding up its new model launch pipeline by launching 5 new models this year
  • If all go to plan, Xpeng’s sales may hit 30k vehicles/month end of ’23 or early ’24
  • The appointment of new President from ICE sector may lead to some market confusion on management and branding in the short term

Shanghai MicroPort MedBot Group (2252.HK) – Recognize the Reality but Don’t Give up Hope

By Xinyao (Criss) Wang

  • New policy about surgical robots was released, which is conducive to the promotion and popularization of surgical robots in China. However, the situation is not as simple as it seems.
  • We deep dive the business environment of surgical robots in China.Even with favorable policies, both surgical robot systems and consumables have to reduce price largely so as to be affordable.
  • It’s difficult to make profits in China. Medbot could lose money for quite some time.Without solid internationalization, the rally cannot be sustained for a long time only by policy catalyst.

Aequitas ASEAN Placements Bookrunner Performance (2019-2022)

By Ethan Aw

  • In this note, we will take a look at the performance of bookrunners for ASEAN placements from 2019-2022.
  • The following dataset includes all ASEAN placements above US$100m for the period of Calendar Years 2019-2022, which amounted to a total of 54 deals.
  • The deals you see in this note are based on our historical placements tracker. Feel free to drop us a message for additional information on any of these placements.

Morning Views Asia:

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


    China’s Green Loan Market: Fifty Shades of Green

    By Stanley Tsai, CFA

    • The PBOC has extended the use of its policy tools to support the green loan industry as part of the country’s’ drive towards carbon neutrality.
    • China’s green loan market is already the largest in the world, if you agree with its definitions and can look past its limitations.
    • The state of green finance matters to investors, and not just those with explicit ESG mandates. We look at the potential pitfalls in the China.

    💡 Before it’s here, it’s on Smartkarma

    Sign Up for Free

    The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

    • ✓ Unlimited Research Summaries
    • ✓ Personalised Alerts
    • ✓ Custom Watchlists
    • ✓ Company Data and News
    • ✓ Events & Webinars

    Daily Brief Japan: Nissan Motor, AXXZIA Inc, SBI Holdings, H2O Retailing, NEC Corp, Nihon M&A Center, Tobila Systems Inc and more

    By | Daily Briefs, Japan

    In today’s briefing:

    • Renault & Nissan “Agree” On New Terms – A Diet Nothing🍔, Exchangeable into Shaq Fingerguns
    • TOPIX Inclusion: AXXZIA Inc (4936 JP) – Time to Take Profits
    • JPX-Nikkei 400 Rebal 2023: End-Jan 2023
    • Japanese Department Stores: An Opportunity to Trade FQ3 Earnings This Week
    • NEC (6701) | Strong Network Revenues
    • Nihon M&A: Weak Earnings and Guidance for Full-Year Seems Too Optimistic
    • Tobila Systems: A Deep-Dive View

    Renault & Nissan “Agree” On New Terms – A Diet Nothing🍔, Exchangeable into Shaq Fingerguns

    By Travis Lundy

    • Today, a Nikkei article suggested (after other media suggested last week) that Renault SA (RNO FP) and Nissan Motor (7201 JP) have come to agreement about their new deal.
    • Post-Close, an announcement. Two striking things about this “agreement” a) it comes many months after they started negotiating, and b) we have few details, and c) we’re missing a bit.
    • Renault agrees to cap voting rights in Nissan. Nissan agrees to invest in RNO’s EV spinoff, and so far, they agree to strengthen the Alliance. What’s missing is interesting/key.

    TOPIX Inclusion: AXXZIA Inc (4936 JP) – Time to Take Profits

    By Janaghan Jeyakumar, CFA


    JPX-Nikkei 400 Rebal 2023: End-Jan 2023

    By Janaghan Jeyakumar, CFA

    • JPX-Nikkei 400 is composed of common stocks listed on the Tokyo Stock Exchange. It is a free-float-adjusted market-value-weighted (capped) index composed of 400 constituents.
    • A periodic review is conducted by the Index providers, the JPX Group and Nikkei Inc, in August every year. We look at the potential forward inclusions and removals every month.
    • Below is a look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2023 based on trading data as of end-January 2023.

    Japanese Department Stores: An Opportunity to Trade FQ3 Earnings This Week

    By Oshadhi Kumarasiri


    NEC (6701) | Strong Network Revenues

    By Mark Chadwick

    • We remain bullish on NEC as we believe that the company is one of the key beneficiaries of the shift to standalone 5G
    • NEC’s Network Services registered double-digit revenue and profit gains in Q3 on the back of growth in 5G equipment sales and IP income.
    • We believe that the current share price (+4% over the past 12m) and valuation (10x PE, 0.8x PB) do not reflect the positive mid-term outlook

    Nihon M&A: Weak Earnings and Guidance for Full-Year Seems Too Optimistic

    By Shifara Samsudeen, ACMA, CGMA

    • Nihon M&A Center (2127 JP) reported 3QFY03/2022 results. Revenue declined 9.9% YoY to JPY9.8bn (vs consensus JPY13.6bn) while OP dropped 21.9% YoY to JPY3.2bn (vs consensus JPY6.1bn).
    • Though there had been an increase in the no. of transactions completed during the quarter, revenue declined due to price pressures.
    • Share price has declined 22.8% during today’s trade due to weaker-than-expected earnings and we think full-year FY03/2022E guidance is too hard to achieve.

    Tobila Systems: A Deep-Dive View

    By Steven Chen

    • This is our second Insight into Tobila Systems – the absolute dominator in the niche of fraud/spam call and message filtering services in Japan;
    • We like the high-quality, unique assets owned by the company, although capital allocation appears to stand out as a wild card in our formula of long-term shareholder-value creation;
    • At the current level, we would hold the shares firmly and wait patiently for more opportunistic offerings from Mr. Market to accumulate more shares.

    💡 Before it’s here, it’s on Smartkarma

    Sign Up for Free

    The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

    • ✓ Unlimited Research Summaries
    • ✓ Personalised Alerts
    • ✓ Custom Watchlists
    • ✓ Company Data and News
    • ✓ Events & Webinars